Drug Profile
Benzoyl peroxide/tretinoin - Sol-Gel Technologies
Alternative Names: Microencapsulated benzoyl peroxide 3% and microencapsulated tretinoin 0.1% cream; S6G5T 1/S6G5T 3; Tretinoin/benzoyl-peroxide; TWIN; TwyneoLatest Information Update: 15 Jun 2023
Price :
$50
*
At a glance
- Originator Sol-Gel Technologies
- Class Anti-infectives; Antiacnes; Benzoic acids; Keratolytics; Oxidants; Retinoids; Skin disorder therapies; Small molecules
- Mechanism of Action Protein synthesis inhibitors; Retinoic acid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Marketed Acne vulgaris
Most Recent Events
- 06 Jun 2023 Searchlight Pharma in licenses Benzoyl peroxide/tretinoin from Sol-gel Technologies for commercialization in Canada
- 27 Jan 2023 Benzoyl peroxide/tretinoin - Sol-Gel Technologies is available for licensing in World (excluding USA) as of 27 Jan 2023. https://www.sol-gel.com/
- 25 Mar 2022 Launched for Acne vulgaris (In adolescents, In children, In the elderly, In adults) in USA - First global launch (Topical)